SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19434460
Source:
http://linkedlifedata.com/resource/pubmed/id/19434460
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0031809
,
umls-concept:C0149925
,
umls-concept:C0302350
,
umls-concept:C0871261
,
umls-concept:C0872169
,
umls-concept:C1704632
,
umls-concept:C1706817
,
umls-concept:C2911692
pubmed:issue
6
pubmed:dateCreated
2009-10-19
pubmed:abstractText
We evaluated the ability of 2-deoxy-2-(18)F-fluoro-D-glucose (FDG) positron emission tomography (PET) in the early assessment of therapeutic response in patients with small cell lung cancer (SCLC).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/101125610
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin
,
http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide
,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorodeoxyglucose F18
,
http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals
,
http://linkedlifedata.com/resource/pubmed/chemical/irinotecan
pubmed:status
MEDLINE
pubmed:issn
1860-2002
pubmed:author
pubmed-author:BandohSS
,
pubmed-author:IshiiTT
,
pubmed-author:KameyamaRR
,
pubmed-author:MurotaMM
,
pubmed-author:NishiyamaYY
,
pubmed-author:YamamotoYY
pubmed:issnType
Electronic
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
467-72
pubmed:meshHeading
pubmed-meshheading:19434460-Aged
,
pubmed-meshheading:19434460-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:19434460-Camptothecin
,
pubmed-meshheading:19434460-Carboplatin
,
pubmed-meshheading:19434460-Cisplatin
,
pubmed-meshheading:19434460-Etoposide
,
pubmed-meshheading:19434460-Female
,
pubmed-meshheading:19434460-Fluorodeoxyglucose F18
,
pubmed-meshheading:19434460-Humans
,
pubmed-meshheading:19434460-Lung Neoplasms
,
pubmed-meshheading:19434460-Male
,
pubmed-meshheading:19434460-Middle Aged
,
pubmed-meshheading:19434460-Positron-Emission Tomography
,
pubmed-meshheading:19434460-Prospective Studies
,
pubmed-meshheading:19434460-Radiopharmaceuticals
,
pubmed-meshheading:19434460-Small Cell Lung Carcinoma
,
pubmed-meshheading:19434460-Treatment Outcome
pubmed:articleTitle
Early assessment of therapeutic response using FDG PET in small cell lung cancer.
pubmed:affiliation
Department of Radiology, Faculty of Medicine, Kagawa University, Kita-gun, Kagawa, Japan. yuka@kms.ac.jp
pubmed:publicationType
Journal Article
,
Evaluation Studies